Technical Analysis for NEO - NeoGenomics, Inc.

Grade Last Price % Change Price Change
D 48.17 0.63% 0.30
NEO closed up 0.63 percent on Friday, April 9, 2021, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Apr 26
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical NEO trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
NR7 Range Contraction 0.00%
Hammer Candlestick Bullish 0.63%
Pocket Pivot Bullish Swing Setup 0.63%
Fell Below 20 DMA Bearish 2.58%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.31%
Multiple of Ten Bearish Other -1.31%
Outside Day Range Expansion -1.31%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.31%
Narrow Range Bar Range Contraction -2.31%
Older End-of-Day Signals for NEO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeoGenomics, Inc. Description

NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company's trademarks include NeoFISH, NeoFlow, NeoSITE, NeoArray, NeoType, and MelanoSITE. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Diseases Lymphoma Telemedicine Telehealth Genetics Genomics Lab Testing Medical Tests Leukemia Bladder Cancer Anatomical Pathology Laboratory Techniques Solid Tumor Cancers Flow Cytometry Fort Myers Neos Hybridization Cytogenetics Neogen

Is NEO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 61.57
52 Week Low 25.19
Average Volume 902,472
200-Day Moving Average 44.40
50-Day Moving Average 50.92
20-Day Moving Average 48.31
10-Day Moving Average 47.31
Average True Range 2.32
ADX 12.49
+DI 21.02
-DI 24.87
Chandelier Exit (Long, 3 ATRs ) 45.86
Chandelier Exit (Short, 3 ATRs ) 50.31
Upper Bollinger Band 52.05
Lower Bollinger Band 44.57
Percent B (%b) 0.48
BandWidth 15.49
MACD Line -0.69
MACD Signal Line -0.96
MACD Histogram 0.2753
Fundamentals Value
Market Cap 5.35 Billion
Num Shares 111 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 1416.76
Price-to-Sales 11.87
Price-to-Book 7.85
PEG Ratio 3.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.00
Resistance 3 (R3) 49.85 49.09 49.70
Resistance 2 (R2) 49.09 48.62 49.17 49.60
Resistance 1 (R1) 48.63 48.34 48.86 48.78 49.49
Pivot Point 47.87 47.87 47.98 47.94 47.87
Support 1 (S1) 47.41 47.40 47.64 47.56 46.85
Support 2 (S2) 46.65 47.11 46.72 46.74
Support 3 (S3) 46.19 46.65 46.64
Support 4 (S4) 46.34